2026-09-20T14:08:50Zhttps://dspace.mit.edu/server/oai/requestoai:dspace.mit.edu:1721.1/355412026-06-06T01:03:56Zcom_1721.1_7582com_1721.1_7581com_1721.1_101402col_1721.1_131023col_1721.1_101610
Chris Caplice.
Bourassa, P. Louis (Pierre Louis)
Massachusetts Institute of Technology. Engineering Systems Division.
Massachusetts Institute of Technology. Engineering Systems Division
2007-01-10T16:35:25Z
2007-01-10T16:35:25Z
2006
2006
http://hdl.handle.net/1721.1/35541
72823410
Thesis (M. Eng. in Logistics)--Massachusetts Institute of Technology, Engineering Systems Division, 2006.
Includes bibliographical references (p. 85).
The selection of a transportation alternative to ship perishable goods is dependent on several interconnected factors, the most important usually being speed of delivery. This study focuses on the distribution operation of Tyco Healthcare's (THC's) nuclear medicine group in the continental United States. It studies the system constraints, service requirements and costs involved in shipping highly perishable radiopharmaceuticals. The first stage of the study describes aspects of THC's radiopharmaceutical supply chain from order taking at the manufacturing plant to distribution of the prepared doses at the radiopharmacies. The second stage establishes the unit costs of shipping products to three sample regions via the four transportation alternatives currently used: ground courier, FedEx Express, commercial airline and chartered aircraft. The third and final stage of the study analyzes three hypothetical distribution scenarios. Its purpose was to challenge the restrictions and determine the opportunity cost of distributing the nuclear medicine under the current operating policies. Based on the results of all three stages, a set of cost savings recommendations is provided.
by P. Louis Bourassa.
M.Eng. in Logistics
85 p.
3729315 bytes
3733188 bytes
application/pdf
application/pdf
eng
Massachusetts Institute of Technology
M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
http://dspace.mit.edu/handle/1721.1/7582
Engineering Systems Division.
Choosing transportation alternatives for highly perishable goods
Thesis
application/pdf
Publication
unknown
unknown
<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="d24b486d-0489-4f14-8d73-157421e44429">
<Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type>
<Language>eng</Language>
<Title>Choosing transportation alternatives for highly perishable goods</Title>
<PublishedIn>
<Publication>
</Publication>
</PublishedIn>
<PublicationDate>2006</PublicationDate>
<Authors>
<Author>
<DisplayName>Bourassa, P. Louis (Pierre Louis)</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
</Authors>
<Editors>
</Editors>
<Publishers>
<Publisher>
<DisplayName>Massachusetts Institute of Technology</DisplayName>
<OrgUnit />
</Publisher>
</Publishers>
<License>http://dspace.mit.edu/handle/1721.1/7582</License>
<Keyword>Engineering Systems Division.</Keyword>
<Abstract>The selection of a transportation alternative to ship perishable goods is dependent on several interconnected factors, the most important usually being speed of delivery. This study focuses on the distribution operation of Tyco Healthcare's (THC's) nuclear medicine group in the continental United States. It studies the system constraints, service requirements and costs involved in shipping highly perishable radiopharmaceuticals. The first stage of the study describes aspects of THC's radiopharmaceutical supply chain from order taking at the manufacturing plant to distribution of the prepared doses at the radiopharmacies. The second stage establishes the unit costs of shipping products to three sample regions via the four transportation alternatives currently used: ground courier, FedEx Express, commercial airline and chartered aircraft. The third and final stage of the study analyzes three hypothetical distribution scenarios. Its purpose was to challenge the restrictions and determine the opportunity cost of distributing the nuclear medicine under the current operating policies. Based on the results of all three stages, a set of cost savings recommendations is provided.</Abstract>
<Access xmlns="http://purl.org/coar/access_right"
>
</Access>
</Publication>